🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 149 of 857 · Phase 3 first, then by program name

  1. Powder for reconstitution for enteral administration

    Lacuna Pharma Pty Ltd

    Intestinal Malabsorption

    phase 3 small molecule active

    1 trial

  2. Powder for reconstitution for enteral administration

    Lacuna Pharma Pty Ltd

    Intestinal Malabsorption

    phase 3 small molecule active

    1 trial

  3. Pozelimab

    Regeneron UK Limited

    CD55-deficient Protein-losing Enteropathy

    phase 3 small molecule completed

    1 trial

  4. Pozelimab

    Regeneron UK Limited

    Age-related Macular Degeneration (AMD)

    phase 3 small molecule active

    1 trial

  5. Pozelimab

    Regeneron UK Limited

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule active

    4 trials

  6. Pozelimab + Cemdisiran

    Regeneron UK Limited

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  7. Pozelimab, Cemdisiran

    Lacuna Pharma Pty Ltd

    Paroxysmal nocturnal hemoglobinuria (PNH)

    phase 3 small molecule active

    1 trial

  8. Pramipexol Extended Release

    Boehringer Ingelheim

    Early Parkinson Disease (Early PD)

    phase 3 small molecule completed

    1 trial

  9. Pravafenix 40 mg/160 mg hard capsules

    Laboratoire HRA Pharma

    Dyslipidaemia

    phase 3 small molecule active

    1 trial

  10. Pravastatina Kern Pharma 40 mg comprimidos EFG, Placebo Pravastatina

    The George Institute

    intrauterine growth restriction, preeclampsia

    phase 3 small molecule active

    1 trial

  11. Pred Forte 10 mg/ml colirio en suspensión, Clobetasol propionate ophthalmic nanoemulsion, 0.05%

    Laboratorios Tillomed Spain S.L.U

    Inflammation and pain associated with ocular surgery

    phase 3 small molecule active

    1 trial

  12. Prednisolon 1 mg JENAPHARM, Prednisolon 5 mg JENAPHARM, Prednisolone placebo-5mg, Prednisolon 20 mg JENAPHARM, Prednisolone placebo-10mg, Prednisolon 10 mg JENAPHARM, Upadacitinib placebo, Upadacitinib, Prednisolone placebo-20mg, Prednisolone placebo-1mg, Upadacitinib

    AbbVie Deutschland GmbH & Co. KG

    Giant Cell Arteritis

    phase 3 small molecule active

    1 trial

  13. Prednisolon STADA® 5 mg Tabletten, Prednisolone placebo hard capsule and tablet, Normal Saline, Prednisolon STADA® 10 mg Tabletten, [1-13C]SODIUM ACETATE, Avalotcagene ontaparvovec

    Lacuna Pharma Pty Ltd

    Late-onset Ornithine transcarbamylase (OTC) deficiency

    phase 3 small molecule active

    1 trial

  14. Prednisolon STADA® 5 mg Tabletten, Prednisolone placebo hard capsule, 10 mg, Prednisolone Placebo hard capsule, 5mg, Prednisolon STADA® 10 mg Tabletten, Pariglasgene brecaparvovec, Normal Saline

    Lacuna Pharma Pty Ltd

    Glycogen Storage Disease Type Ia (GSDIa)

    phase 3 small molecule active

    1 trial

  15. Prednisolone

    United Therapeutics Europe Ltd

    Adrenal Insufficiency

    phase 3 small molecule active

    1 trial

  16. Prednisolone 10mg Tablets, Avastin 25 mg/ml concentrate for solution for infusion., Sodium Chloride Fresenius Kabi Italia 0.9 % Solution for infusion

    CERO THERAPEUTICS HOLDINGS, INC.

    Brain metastases of cancer > brain radionecrosis

    phase 3 small molecule active

    1 trial

  17. Pregabalin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Herpetic Neuralgia

    phase 3 small molecule active

    1 trial

  18. Pregabalin Dose Level 1

    Pfizer

    Partial Onset Seizures

    phase 3 small molecule completed

    1 trial

  19. Preoperative hepatic and regional arterial chemotherapy using oxaliplatin, MMC and FUDR

    The First People's Hospital of Lianyungang

    Colorectal Neoplasms

    phase 3 other active

    1 trial

  20. Pretomanid

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis, Pulmonary

    phase 3 small molecule completed

    2 trials

  21. Prevnar 13™

    Merck KGaA, Darmstadt, Germany

    Pneumococcal Infections

    phase 3 mab completed

    1 trial

  22. Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln-Lebendimpfstoff, Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln-Lebendimpfstoff, VARIVAX® Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension in einer Fertigspritze Varizellen-Lebendimpfstoff, Priorix - Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze|Masern-Mumps-Röteln

    GlaxoSmithKline

    Varicella

    phase 3 small molecule active

    1 trial

  23. Privigen 100 mg/ml solution for infusion, Fortecortin® 2 mg Tabletten, Dexamethason 8 mg GALEN® Tabletten, Privigen 100 mg/ml solution for infusion, teclistamab, JNJ-64407564, Pomalidomide, Dexamethasone Tablets BP 2.0mg, Imnovid 3 mg hard capsules, Pomalidomide, Imnovid 1 mg hard capsules, Empliciti 400 mg powder for concentrate for solution for infusion., Empliciti 300 mg powder for concentrate for solution for infusion., Pomalidomide, VELCADE 3.5 mg powder for solution for injection, Privigen 100 mg/ml s

    Janssen-Cilag International N.V.

    Relapsed or Refractory Myeloma

    phase 3 small molecule active

    1 trial

  24. Privigen 100 mg/ml solution for infusion, Gammanorm, 165 mg/ml, oplossing voor injectie, Octagam 10%, oplossing voor infusie, Nanogam 100 mg/ml oplossing voor infusie, Hizentra 200 mg/ml solution for subcutaneous injection, HyQvia 100 mg/ml solution for infusion for subcutaneous use, Cuvitru 200 mg/ml oplossing voor subcutane injectie, KIOVIG 100 mg/ml solution for infusion, CUTAQUIG 165 mg/mL, solution injectable, GAMMAGARD S/D 5,0 g, poeder en oplosmiddel voor oplossing voor infusie.

    Disc Medicine

    Primary antibody deficiency: - Unclassified antibody deficiency (unPAD) - IgA deficiency - Specific polysaccharide antibody deficiency (SPAD) - IgG subclass deficiency (IgSD) - Common variable immunodeficiency (CVID) - Agammaglobulinemia (X-linked or otherwise)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources